Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Uterus”

586 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 586 results

Testing effectiveness (Phase 2)Study completedNCT00510250
What this trial is testing

A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer

Who this might be right for
Cancer of the Cervix
University Health Network, Toronto 13
Very early researchLooking for participantsNCT06639191
What this trial is testing

[177Lu]Lu-AKIR001 First-in-human Study

Who this might be right for
Thyroid Gland Anaplastic CarcinomaPoorly Differentiated Thyroid CarcinomaCancer Head and Neck+3 more
Karolinska University Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Not applicableUnknownNCT04528940
What this trial is testing

Tumor Grade Determines PD-1/PDL-1 Expression

Who this might be right for
Endometrial CancerOvarian Cancer
RWJ Barnabas Health at Jersey City Medical Center 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793318
What this trial is testing

TR115 in ARID1A-Mutated Advanced Solid Tumors

Who this might be right for
Ovarian Clear Cell CarcinomaEndometrial CancerStomach Cancer Recurrent+1 more
Tarapeutics Science Inc. 50
Early research (Phase 1)Study completedNCT01975831
What this trial is testing

Evaluate MEDI4736 in Combination With Tremelimumab

Who this might be right for
Breast CancerOvarian CancerColorectal Cancer+2 more
Ludwig Institute for Cancer Research 104
Testing effectiveness (Phase 2)Study completedNCT03476798
What this trial is testing

Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium

Who this might be right for
Cervical CancerEndometrial Cancer
University of Oklahoma 49
Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Testing effectiveness (Phase 2)Ended earlyNCT01251354
What this trial is testing

Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy

Who this might be right for
Endometrial Cancer
Ipsen 6
Large-scale testing (Phase 3)Study completedNCT03556839
What this trial is testing

Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix

Who this might be right for
Carcinoma of the Cervix, Stage IVB
Grupo Español de Investigación en Cáncer de Ovario 410
Early research (Phase 1)UnknownNCT04432857
What this trial is testing

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Who this might be right for
Triple-negative Breast CancerNSCLC, Squamous or Non-SquamousUrothelial Carcinoma of the Bladder+2 more
Adlai Nortye Biopharma Co., Ltd. 63
Large-scale testing (Phase 3)Active Not RecruitingNCT02466971
What this trial is testing

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Who this might be right for
Advanced Vaginal AdenocarcinomaAdvanced Vaginal Adenosquamous CarcinomaAdvanced Vaginal Squamous Cell Carcinoma+18 more
National Cancer Institute (NCI) 450
Testing effectiveness (Phase 2)Study completedNCT05864144
What this trial is testing

SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more
Sensei Biotherapeutics, Inc. 98
Not applicableStudy completedNCT00124488
What this trial is testing

Comparison of Tomotherapy Versus Intensity-modulated Step-and-shoot and Conventional Radiation Treatment Plans for Patients With Locally-advanced Squamous Cell Carcinoma of the Cervix

Who this might be right for
Cervix Neoplasm
Alberta Health services 10
Testing effectiveness (Phase 2)WithdrawnNCT04030000
What this trial is testing

Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation

Who this might be right for
Uterine Carcinoma
Northwell Health
Early research (Phase 1)Study completedNCT04504669
What this trial is testing

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more
AstraZeneca 60
Testing effectiveness (Phase 2)Study completedNCT00334295
What this trial is testing

Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.

Who this might be right for
Endometrial Carcinoma
AstraZeneca 35
Testing effectiveness (Phase 2)Looking for participantsNCT06640283
What this trial is testing

Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes

Who this might be right for
HPV-Related CarcinomaUterine Cervical CancerAnal Canal Cancer+2 more
Instituto do Cancer do Estado de São Paulo 150
Not applicableWithdrawnNCT04889495
What this trial is testing

A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer

Who this might be right for
Non-small Cell Lung CancerMetastatic Colorectal CancerMetastatic Breast Cancer+5 more
Pfizer
Testing effectiveness (Phase 2)Study completedNCT05795595
What this trial is testing

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more
CRISPR Therapeutics AG 19
Next Page